Trial Identifiers
Use the hyperlinks, where available to access additional clinical trial information.
Trial sponsor
GORTEC (Head and Neck Oncology and Radiotherapy Group)
Scientific Title
A Randomized, Double-Blind Placebo-Controlled, Phase 3 Study of Debio 1143 in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX)